KEYSTONE MEDICAL DEVICE PARTNERS · FDA READINESS
FDA Readiness. Proven Results.
Keystone Medical Device Partners helps medical device companies prepare for FDA-facing milestones through integrated regulatory strategy, quality systems, verification planning, submission readiness, and disciplined execution.
Risk ID strengthens FDA readiness by connecting hidden-use scenarios to risk controls, requirements, test cases, objective evidence, and residual risk.
Built for confident FDA review.
Regulatory strategy, quality systems, verification evidence, and submission readiness aligned around what FDA will evaluate.
FDA readiness built into the program—not added at the end.
FDA readiness is strongest when regulatory strategy, quality systems, verification planning, and submission requirements are aligned throughout development.
01
Regulatory strategy aligned early.
02
Quality systems connected to execution.
03
Verification and submission readiness planned together.
Readiness that holds up under review.
Keystone Medical Device Partners integrates regulatory strategy, quality systems, verification planning, and submission readiness so programs remain clear, defensible, and ready for FDA-facing milestones.
01
Regulatory strategy aligned with intended use, claims, and submission pathway.
02
Quality systems connected to development decisions, evidence, and execution.
03
Verification and submission readiness planned around the evidence FDA will review.
STRATEGY
Regulatory Strategy
Align intended use, claims, classification, and submission pathway so the regulatory plan guides development from the start.
- Intended-use and claims alignment
- Classification and pathway planning
- Regulatory risk identification
- FDA interaction strategy
ENGINEERING
Quality Systems
Connect design controls, risk management, traceability, and quality records to the decisions and evidence created throughout development.
- Design-control integration
- Risk-management alignment
- Requirements and traceability
- Quality-record readiness
EXECUTION
Submission Readiness
Plan verification, validation, and submission evidence around what FDA will review so the program remains clear, complete, and defensible.
- Verification and validation planning
- Evidence-gap assessment
- Submission-content readiness
- Review-response preparation
Commercial milestones require GMP-ready execution
FDA readiness does not stop at the submission package. For many teams, the larger business goal depends on proving the product can operate inside a controlled, documented, GMP-ready workflow.
CUSTOMER RESULT
Synthetic Genomics Inc.
Our experts helped Synthetic Genomics Inc. bring their DNA Instrument onto the GMP workflow, supporting the business unit’s ability to move toward a successful sale.
GMP Workflow Integration
We help connect instrument use, quality records, process controls, documentation, training, and manufacturing expectations so the workflow can support regulated business goals.
Business value created
The right readiness work protects the product story and strengthens the commercial story—especially when diligence, acquisition, or scale-up pressure is high.
Ready to move your device program forward?
Tell us where your program stands, and we’ll help identify the clearest path forward.
Keystone Medical Device Partners 